The Battlefield of Chemotherapy in Pediatric Cancers
Cancers · 24.03.2023 · 15 (7) · 1963
DOI: 10.3390/cancers15071963 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 24.03.2023. Verfasst von Letao Bo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Plan of Jiangxi Provincial Health Commission, Guiding Science and Technology Programme of Ganzhou city.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The survival rate for pediatric cancers has remarkably improved in recent years. Conventional chemotherapy plays a crucial role in treating pediatric cancers, especially in low- and middle-income countries where access to advanced treatments may be limited. The Food and Drug Administration (FDA) approved chemotherapy drugs that can be used in children have expanded, but patients still face numerous side effects from the treatment. In addition, multidrug resistance (MDR) continues to pose a major challenge in improving the survival rates for a significant number of patients. This review focuses on the severe side effects of pediatric chemotherapy, including doxorubicin-induced cardiotoxicity (DIC) and vincristine-induced peripheral neuropathy (VIPN). We also delve into the mechanisms of MDR in chemotherapy to the improve survival and reduce the toxicity of treatment. Additionally, the review focuses on various drug transporters found in common types of pediatric tumors, which could offer different therapeutic options.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
- Ganzhou Key Laboratory of Hematology, Department of Hematology, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China.
- Institute for Biotechnology, St. John's University, Queens, NY 11439, USA.
ORCID-Profile: Letao Bo, Zhe-Sheng Chen
Förderung
- Science and Technology Plan of Jiangxi Provincial Health Commission
- Guiding Science and Technology Programme of Ganzhou city
Zitieren
APA
Bo, L., Wang, Y., Li, Y., Wurpel, J. N. D., Huang, Z., & Chen, Z. S. (2023). The Battlefield of Chemotherapy in Pediatric Cancers. Cancers, 15(7), 1963. https://doi.org/10.3390/cancers15071963
Vancouver
Bo L, Wang Y, Li Y, Wurpel JND, Huang Z, Chen ZS. The Battlefield of Chemotherapy in Pediatric Cancers. Cancers. 2023;15(7):1963. doi:10.3390/cancers15071963
BibTeX
@article{Bo2023,
author = {Bo, Letao and Wang, Youyou and Li, Yidong and Wurpel, John N D and Huang, Zoufang and Chen, Zhe-Sheng},
title = {The Battlefield of Chemotherapy in Pediatric Cancers},
journal = {Cancers},
year = {2023},
volume = {15},
number = {7},
pages = {1963},
doi = {10.3390/cancers15071963}
}
EUVIMED